Literature DB >> 23942088

Effect of DHA and coenzymeQ10 against Aβ- and zinc-induced mitochondrial dysfunction in human neuronal cells.

Nadia Sadli1, Colin J Barrow, Sean McGee, Cenk Suphioglu.   

Abstract

BACKGROUND: Beta-amyloid (Aβ) protein is a key factor in the pathogenesis of Alzheimer's disease (AD) and it has been reported that mitochondria is involved in the biochemical pathway by which Aβ can lead to neuronal dysfunction. Coenzyme Q10 (CoQ10) is an essential cofactor involved in the mitochondrial electron transport chain and has been suggested as a potential therapeutic agent in AD. Zinc toxicity also affects cellular energy production by decreasing oxygen consumption rate (OCR) and ATP turnover in human neuronal cells, which can be restored by the neuroprotective effect of docosahexaenoic acid (DHA).
METHOD: In the present study, using Seahorse XF-24 Metabolic Flux Analysis we investigated the effect of DHA and CoQ10 alone and in combination against Aβ- and zinc-mediated changes in the mitochondrial function of M17 neuroblastoma cell line.
RESULTS: Here, we observed that DHA is specifically neuroprotective against zinc-triggered mitochondrial dysfunction, but does not directly affect Aβ neurotoxicity. CoQ10 has shown to be protective against both Aβ- and zinc-induced alterations in mitochondrial function.
CONCLUSION: Our results indicate that DHA and CoQ10 may be useful for the prevention, treatment and management of neurodegenerative diseases such as AD.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23942088     DOI: 10.1159/000354433

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  6 in total

1.  Omega-3 fatty acid obtained from Nannochloropsis oceanica cultures grown under low urea protect against Abeta-induced neural damage.

Authors:  Ying-Jang Lai
Journal:  J Food Sci Technol       Date:  2014-04-23       Impact factor: 2.701

Review 2.  Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots.

Authors:  Shao-Hua Yang; Wenjun Li; Nathalie Sumien; Michael Forster; James W Simpkins; Ran Liu
Journal:  Prog Neurobiol       Date:  2015-11-18       Impact factor: 11.685

3.  Mechanistic perspectives on differential mitochondrial-based neuroprotective effects of several carnitine forms in Alzheimer's disease in vitro model.

Authors:  Sandra I Mota; Inês Pita; Rodolfo Águas; Slah Tagorti; Ashraf Virmani; Frederico C Pereira; A Cristina Rego
Journal:  Arch Toxicol       Date:  2021-06-24       Impact factor: 5.153

Review 4.  Mitochondria as Potential Targets in Alzheimer Disease Therapy: An Update.

Authors:  Giovanna Cenini; Wolfgang Voos
Journal:  Front Pharmacol       Date:  2019-08-23       Impact factor: 5.810

5.  "Iron free" zinc oxide nanoparticles with ion-leaking properties disrupt intracellular ROS and iron homeostasis to induce ferroptosis.

Authors:  Changping Zhang; Zixuan Liu; Yuhao Zhang; Liang Ma; Erqun Song; Yang Song
Journal:  Cell Death Dis       Date:  2020-03-13       Impact factor: 8.469

Review 6.  Ubisol-Q10, a Nanomicellar and Water-Dispersible Formulation of Coenzyme-Q10 as a Potential Treatment for Alzheimer's and Parkinson's Disease.

Authors:  Darcy Wear; Caleb Vegh; Jagdeep K Sandhu; Marianna Sikorska; Jerome Cohen; Siyaram Pandey
Journal:  Antioxidants (Basel)       Date:  2021-05-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.